BACCARANI, Umberto
 Distribuzione geografica
Continente #
NA - Nord America 18.490
EU - Europa 5.706
AS - Asia 3.578
SA - Sud America 510
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 5
Totale 28.366
Nazione #
US - Stati Uniti d'America 18.356
SG - Singapore 1.803
UA - Ucraina 1.661
DE - Germania 1.303
CN - Cina 1.102
IT - Italia 789
FI - Finlandia 559
RU - Federazione Russa 548
BR - Brasile 466
IE - Irlanda 319
TR - Turchia 189
SE - Svezia 175
KR - Corea 135
CA - Canada 108
GB - Regno Unito 99
FR - Francia 83
IN - India 73
VN - Vietnam 72
IR - Iran 55
HK - Hong Kong 49
BE - Belgio 31
CZ - Repubblica Ceca 27
AT - Austria 26
EU - Europa 20
AR - Argentina 19
PL - Polonia 19
NL - Olanda 18
BD - Bangladesh 14
MX - Messico 14
EG - Egitto 13
ZA - Sudafrica 12
KE - Kenya 11
TG - Togo 11
IQ - Iraq 10
ES - Italia 9
TW - Taiwan 8
JO - Giordania 7
PK - Pakistan 7
VE - Venezuela 7
AZ - Azerbaigian 6
MA - Marocco 6
UZ - Uzbekistan 6
CH - Svizzera 5
LA - Repubblica Popolare Democratica del Laos 5
LT - Lituania 5
AM - Armenia 4
AU - Australia 4
BG - Bulgaria 4
CL - Cile 4
IL - Israele 4
NO - Norvegia 4
PA - Panama 4
PE - Perù 4
PH - Filippine 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
EE - Estonia 3
GR - Grecia 3
HR - Croazia 3
JM - Giamaica 3
JP - Giappone 3
KG - Kirghizistan 3
RO - Romania 3
SA - Arabia Saudita 3
TH - Thailandia 3
AO - Angola 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
GE - Georgia 2
LI - Liechtenstein 2
MD - Moldavia 2
PY - Paraguay 2
UY - Uruguay 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CR - Costa Rica 1
DZ - Algeria 1
HN - Honduras 1
ID - Indonesia 1
KW - Kuwait 1
KZ - Kazakistan 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
TN - Tunisia 1
Totale 28.366
Città #
Fairfield 2.736
Woodbridge 1.814
Ashburn 1.311
Houston 1.292
Jacksonville 1.164
Chandler 1.137
Wilmington 1.075
Seattle 1.047
Cambridge 977
Singapore 975
Ann Arbor 924
Dearborn 760
Beijing 568
Udine 476
Boardman 392
Princeton 329
Dublin 319
Izmir 171
San Diego 151
Seoul 125
Hefei 77
Ogden 76
Dong Ket 69
Ottawa 69
Los Angeles 67
Norwalk 56
Des Moines 54
Nanjing 50
Hong Kong 49
New York 48
Kunming 47
Helsinki 39
Düsseldorf 33
São Paulo 32
Brussels 31
Munich 30
Milan 28
Washington 27
Guangzhou 26
Redmond 25
Frankfurt am Main 23
Jinan 23
Leawood 22
Nanchang 21
Toronto 21
Augusta 20
Grafing 19
Ardabil 18
Nuremberg 18
Chengdu 17
Monmouth Junction 17
Brno 16
London 16
Pune 16
San Mateo 16
Dallas 15
Fuzhou 15
Rio de Janeiro 15
Rome 15
Santa Clara 15
Shanghai 15
Trieste 15
Turku 15
Phoenix 14
Vienna 13
Zanjan 13
Hyderabad 12
Lauterbourg 12
Porto Alegre 12
Simi Valley 12
Boston 11
Brooklyn 11
Lomé 11
Nairobi 11
Warsaw 11
San Francisco 10
Zhengzhou 10
Belo Horizonte 9
Ningbo 9
Brasília 8
Cairo 8
Charlotte 8
Mexico City 8
Moscow 8
Olomouc 8
Redwood City 8
Shenyang 8
Shenzhen 8
Stockholm 8
Wuhan 8
Hebei 7
Taipei 7
Xian 7
Ankara 6
Auburn Hills 6
Campinas 6
Changsha 6
Dhaka 6
Fortaleza 6
Portsmouth 6
Totale 19.411
Nome #
Extended Ureteral Stricture Corrected with Appendiceal Replacement in a Kidney Transplant Recipient 238
In vitro functional assessment of a porcine hepatocytes based bioartificial liver 198
Steatosis of the graft is a risk factor for posttransplantation biliary complications. 178
LONG-TERM OUTCOMES OF ORTHOTOPIC LIVER TRANSPLANTATION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS AND COMPARISON WITH HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE CASES 174
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. 173
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study 170
Which Type of Incision for Liver Transplantation? 167
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European liver transplant registry 165
A single-center experience of late retransplantation of the liver. 165
A comparative prospective study of two available solutions for kidney and liver preservation 159
Laparoscopic sleeve gastrectomy as a weight reduction strategy in obese patients after kidney transplantation 152
ROLE OF CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS IN PATIENTS WITH DE NOVO COLON CANCER AFTER RENAL TRANSPLANTATION. 151
La splenectomia laparotomica e laparoscopica 148
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 144
Differential proteomic analysis of hepatocellular carcinoma 144
A Matched Pair Analysis of Multicenter Long-term Follow-up after Split Liver Transplantation with Extended Right Grafts 142
Impact of surgical complications on the risk of hepatocellular carcinoma recurrence after hepatic resection 142
Liver transplantation from old donors into HCV and non-HCV recipients 141
Ileocecal Fistula Caused by Multiple Foreign Magnetic Bodies Ingestion 140
Laparoscopic treatment of symptomatic lymphoceles after kidney transplantation 139
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: A report of three cases 139
Diaphragm rupture in a liver transplant patient under chronic immunosuppressive therapy with sirolimus: rare complication after liver transplantation 138
Splenic Artery Syndrome as a Possible Cause of Late Onset Refractory Ascites after Liver Transplantation: Management with Proximal Splenic Artery Embolization 138
Development of Small Bowel Volvulus on Barbed V-Loc™ Suture: A Rare Complication after Laparoscopic Ventral Rectopexy 138
Impact of new treatment options for hepatitis c virus infection in liver transplantation 138
Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts? 137
Detection of transplant renal artery stenosis with contrast-enhanced ultrasound 135
Postsplenectomy recurrence of idiopathic thrombocitopenic purpura: role of laparoscopic splenectomy in the treatment of accessory spleen 134
Isolation of Human Hepatocytes from Livers Rejected for Liver Transplantation on a National Basis: Results of a 2 Year-Experience 132
Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients 132
Donor safety in living donor liver donation: An Italian multicenter survey 131
DE NOVO TUMORS ARE A MAJOR CAUSE OF LATE MORTALITY AFTER ORTHOTOPIC LIVER TRANSPLANTATION 129
BENEFIT OF LAPAROSCOPY FOR RECTAL RESECTION IN PATIENTS OPERATED SIMULTANEOUSLY FOR SYNCHRONOUS LIVER METASTASES: PRELIMINARY EXPERIENCE. 129
Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study 129
Future of minimally invasive surgery 127
Acute pancreatitis after kidney transplantation. 126
Transesophageal echocardiography in orthotopic liver transplantation: a comprehensive intraoperative monitoring tool 126
Transarterial chemoembolization does not harm the hepatic artery at transplantation 126
Hyperlactacidemia Potentially Due to Linezolid Overexposure in a Liver Transplant Recipient 125
Steatotic versus cirrhotic livers as a source for human hepatocyte isolation 125
Portal vein thrombosis after intraportal hepatocytes transplantation in a liver transplant recipient 124
RENAL ALLOGRAFT PROTECTION WITH EARLY ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ADMINISTRATION 124
Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: A 5-year experience 124
Arterial rupture as the result of fungal arteritis after renal transplantation 123
Cryopreserved human hepatocytes from cell bank: In vitro function and clinical application 123
Treatment of Candida Infections with Fluconazole in Adult Liver Transplant Recipients: Is TDM-guided Dosing Adaptation Helpful? 122
Single-time kidney transplantation and monolateral nephrectomy for hypertension and antihypertensive therapy in renal transplant recipients 122
Sequential versus contemporaneous portal and arterial reperfusion during liver transplantation. 122
Biliary pharmacodynamic exposure to linezolid in two liver transplant patients. 121
COMBINED APPROACH FOR SPONTANEOUS RUPTURE OF HEPATOCELLULAR CARCINOMA 121
Complete Remission of Unresectable Hepatocellular Carcinoma after Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization 121
Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients 120
STEATOSIS OF THE HEPATIC GRAFT AS A RISK FACTOR FOR POST-TRANSPLANT BILIARY COMPLICATIONS 120
Quality-of-life assessment before and after liver transplantation. 119
De Novo Solid Tumors after Kidney Transplantation: Is It Time for a Patient-Tailored Risk Assessment? Experience from a Single Center 119
Predictors of endoscopic treatment outcome in the management of biliary complications after orthotopic liver transplantation 119
Pharmacokinetic drug interaction between everolimus and antifungal triazoles in a liver transplant patient 119
Comparison of clinical and pathological staging and long-term results of liver transplantation for hepatocellular carcinoma in a single transplant center 118
De novo malignancies after liver and kidney transplantations: A single center experience on 582 consecutive cases. 118
De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases. 118
Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver 118
Hepatocyte isolation using human livers discarded from transplantation: Analysis of cell yield and function 117
Pharmacokinetic Profile of Prolonged-Release Tacrolimus When Administered via Nasogastric Tube in De Novo Liver Transplantation: A Sub-Study of the DIAMOND Trial 117
Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985–2014 117
Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis 117
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. 116
DE NOVO GASTROINTESTINAL TUMOURS AFTER RENAL TRANSPLANTATION: ROLE OF CMV AND EBV VIRUSES 116
HIV-INFECTED PATIENTS AND LIVER TRANSPLANTATION: WHO, WHEN AND WHY 115
APURINIC APYRIMIDINIC ENDONUCLEASE/REDOX EFFECTOR FACTOR 1 IMMUNOREACTIVITY AND GRADING IN HEPATOCELLULAR CARCINOMA RISK OF RELAPSE AFTER LIVER TRANSPLANTATION 115
IMMUNESUPPRESSION AND CANCER: A COMPARISON OF RISKS IN RECIPIENTS OF ORGAN TRANSPLANTS AND HIV-POSITIVE INDIVIDUALS 115
TREATMENT OF RECURRENT SYMPTOMATIC LYMPHOCELE AFTER KIDNEY TRANSPLANTATION WITH INTRAPERITONEAL TENCKHOFF CATHETER 114
Angiotensin-converting enzyme inhibitors reduce hemoglobin concentrations, hematocrit, and serum erythropoietin levels in renal transplant recipients without posttransplant erythrocytosis 113
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. 113
MeltDose Technology vs Once-Daily Prolonged Release Tacrolimus in De Novo Liver Transplant Recipients 113
Appendicectomy and Crohn's disease: clinical and genetic associations 112
OCCULT HEPATITIS B VIRUS INFECTION IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C: RELATIONSHIP WITH DONOR AGE AND FIBROSIS PROGRESSION 112
. Quantification of human livers as an effective source of hepatocytes for clinical application 111
Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey 111
Steatosis of the hepatic graft as a risk factor for post-transplant biliary complications 110
Successful minimally invasive management of late portal vein thrombosis after splenectomy due to splenic artery steal syndrome following liver transplantation: a case report 110
CARDIOVASCULAR RISK FACTORS AND IMMUNOSUPPRESSIVE REGIMEN AFTER LIVER TRANSPLANTATION 110
Technical solutions for venous outflow reconstruction in damaged liver grafts during procurement: Case reports 110
Surgical staging in Hodgkin's disease: the role of laparoscopic splenectomy 109
Early post-liver transplant surgical morbidity in HIV infected recipients: risk factor for overall survival? A nationwide retrospective study 109
Transient ischemic attack after rizatriptan administration in a liver transplant recipient: A case report 108
Role of cytomegalovirus and Epstein-Barr virus in patients with de novo colon cancer after renal transplantation. 108
Multipotent cells can be generated in vitro from several adult human organs (heart, liver and bone marrow) 108
Liberase HI enzyme versus collagenase type P for porcine hepatocyte isolation 108
Tacrolimus Therapeutic Drug Monitoring in Stable Kidney Transplantation and Individuation of CYP3A5 Genotype 108
Split and whole liver transplantation outcomes: A comparative cohort study 107
Differential Proteomic Analysis of Subfractioned Human Hepatocellular Carcinoma Tissues 107
Role of tumor associated fibroblasts in human liver regeneration, cirrhosis, and cancer. 107
null 107
Non-erosive and uncomplicated erosive reflux diseases: Difference in physiopathological and symptom pattern. 107
Selective bilirubin Removal by Plasma Treatment With Plasorba BR-350 for Early Cholestatic Graft Dysfunction 106
Long-term placement of subcutaneous Rusch-type stents for double biliary stenosis in a living-donor liver transplant recipient 106
Liver resection for hepatocellular carcinoma: A multivariate analysis of factors associated with improved prognosis. The role of clinical, pathological and surgical related factors 106
Cardiovascular and metabolic complications after liver transplantation: Neoral- versus tacrolimus-based immunosuppression 106
RENAL TRANSPLANTATION IN A PATIENT AFFECTED BY MOUNIER-KUHN SYNDROME 106
Head and neck and esophageal cancers after liver transplant: Results from a multicenter cohort study. Italy, 1997-2010 106
Totale 12.712
Categoria #
all - tutte 112.845
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.845


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020442 0 0 0 0 0 0 0 0 0 0 0 442
2020/20214.354 117 473 138 472 284 505 315 534 593 170 515 238
2021/20222.537 109 280 73 128 36 97 168 139 34 472 604 397
2022/20232.588 358 212 41 335 233 701 6 170 337 30 70 95
2023/2024957 115 89 43 26 162 152 12 81 138 55 18 66
2024/20254.691 140 402 202 236 264 304 355 310 611 545 1.170 152
Totale 28.879